Skip to Main Content
ADVERTISEMENT
SCROLL TO CONTINUE WITH CONTENT



Property Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes
Advertisement
International Journal of Infectious Diseases
International Society for Infectious Diseases
Close
  • Home
  • Articles & Issues
    • Back
    • Articles In Press
    • Current Issue
    • List of Issues
    • Supplements
  • Collections
    • Back
    • World TB Day 2021
    • IJID COVID-19
    • Emerging Infectious Diseases in the Time of Ebola
    • Featured Content
  • For Authors
    • Back
    • About Open Access
    • Author Information
    • Permissions
    • Researcher Academy 
    • Submit a Manuscript 
  • Journal Info
    • Back
    • About the Journal
    • About Open Access
    • Contact Information
    • Editorial Board
    • Info for Advertisers 
    • Reprints 
    • New Content Alerts
  • News and Media
  • ISID 
  • ProMED 
  • More Periodicals
    • Back
    • Find a Periodical 
    • Go to Product Catalog 
Advanced searchSave search

Please enter a term before submitting your search.

Ok
  • Submit
  • Log in
  • Register
  • Log in
    • Submit
    • Log in
  • Claim
x

Filter:

Filters applied

  • Coronavirus (COVID-19) Collection
  • Ntoumi, FrancineRemove Ntoumi, Francine filter
  • 2017 - 2022Remove 2017 - 2022 filter
Clear all

Article Type

  • Editorial5
  • Rapid Communication1
  • Research Article1

Author

  • Kock, Richard5
  • Petersen, Eskild4
  • Zumla, Alimuddin4
  • Hui, David S3
  • Ippolito, Giuseppe3
  • Kapata, Nathan3
  • Velavan, Thirumalaisamy P3
  • Asogun, Danny2
  • Azhar, Esam I2
  • Bates, Matthew2
  • Blumberg, Lucille2
  • Dar, Osman2
  • Drosten, Christian2
  • Edwards, Sarah2
  • Haider, Najmul2
  • Hamer, Davidson H2
  • Kremsner, Peter G2
  • Mfoutou Mapanguy, Claujens Chastel2
  • Abdel Hamid, Muzamil Mahdi1
  • Abubakar, Aisha1
  • Aklillu, Eleni1
  • Al-Abri, Seif1
  • Angelov, Angel1
  • Ansumana, Rashid1

Journal

  • International Journal of Infectious Diseases8

Keyword

  • COVID-192
  • Adults1
  • Asymptomatic1
  • Challenges1
  • D614G1
  • HIV1
  • IgG1
  • IgM1
  • Impact1
  • Lineage B11
  • Malaria1
  • Republic of Congo1
  • SARS-CoV-21
  • SARS-CoV-2 variants1
  • TB1
  • The Republic of the Congo1
  • Whole genome sequencing1

Access Filter

  • Open Access

Coronavirus (COVID-19) Collection

8 Results
Subscribe to collection
  • Export
    • PDF
    • Citation

Please select at least one article in order to proceed.

Ok
FilterHide Filter
  • Editorial
    Open Access

    Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts

    International Journal of Infectious Diseases
    Vol. 114p268–272Published online: December 1, 2021
    • Eskild Petersen
    • Francine Ntoumi
    • David S Hui
    • Aisha Abubakar
    • Laura D. Kramer
    • Christina Obiero
    • and others
    Cited in Scopus: 87
    • Preview Hide Preview
    • Download PDF
    • Export Citation
      Nearly two years since the start of the SARS-CoV-2 pandemic, which has caused over 5 million deaths, the world continues to be on high COVID-19 alert. The World Health Organization (WHO), in collaboration with national authorities, public health institutions and scientists have been closely monitoring and assessing the evolution of SARS-CoV-2 since January 2020 (WHO 2021a; WHO 2021b).  The emergence of specific SARS-CoV-2 variants were characterised as Variant of Interest (VOI) and Variant of Concern (VOC), to prioritise global monitoring and research, and to inform the ongoing global response to the COVID-19 pandemic. The WHO and its international sequencing networks continuously monitor SARS-CoV-2 mutations and inform countries about any changes that may be needed to respond to the variant, and prevent its spread where feasible.
    • Perspective
      Open Access

      COVID-19 and syndemic challenges in ‘Battling the Big Three’: HIV, TB and malaria

      International Journal of Infectious Diseases
      Vol. 106p29–32Published online: March 26, 2021
      • Thirumalaisamy P. Velavan
      • Christian G. Meyer
      • Meral Esen
      • Peter G. Kremsner
      • Francine Ntoumi
      • the PANDORA-ID-NET and CANTAM consortium
      Cited in Scopus: 12
      • Preview Hide Preview
      • Download PDF
      • Export Citation
        All countries where malaria is endemic have reported COVID-19 cases. The WHO African Region has experienced >1.5 million cases of COVID-19 (WHO, 2020a) and bears 90% of the global malaria burden. Significant efforts have led to a substantial reduction in malaria deaths in the last decade (WHO, 2019a) and enduring sustainability of malaria interventions and control programs is essential. As signs and symptoms of COVID-19 and malaria partly overlap, diagnostic guidance is inevitable in malaria-endemic settings.
      • Short Communication
        Open Access

        Genomic surveillance of SARS-CoV-2 in the Republic of Congo

        International Journal of Infectious Diseases
        Vol. 105p735–738Published online: March 15, 2021
        • Francine Ntoumi
        • Claujens Chastel Mfoutou Mapanguy
        • Alexandru Tomazatos
        • Srinivas Reddy Pallerla
        • Le Thi Kieu Linh
        • Nicolas Casadei
        • and others
        Cited in Scopus: 11
        • Preview Hide Preview
        • Download PDF
        • Export Citation
          With the first cases reported on March 14, 2020 (Ntoumi and Velavan, 2020), the Republic of Congo reported a total of 7794 cases with 117 deaths as of January 25, 2021, with transmission driven by the community (WHO, 2021).
          Genomic surveillance of SARS-CoV-2 in the Republic of Congo
        • Research Article
          Open Access

          High SARS-CoV-2 IgG/IGM seroprevalence in asymptomatic Congolese in Brazzaville, the Republic of Congo

          International Journal of Infectious Diseases
          Vol. 106p3–7Published online: December 24, 2020
          • Armel Landry Batchi-Bouyou
          • Line Lobaloba Ingoba
          • Matthieu Ndounga
          • Jeannhey Christevy Vouvoungui
          • Claujens Chastel Mfoutou Mapanguy
          • Kamal Rauchelvy Boumpoutou
          • and others
          Cited in Scopus: 8
          • Preview Hide Preview
          • Download PDF
          • Export Citation
            The occurrence of asymptomatic individuals with coronaviruses presents a significant public health issue (Nikolai et al., 2020). As of December 15, 2020, there had been more than 73,557,491 coronavirus disease 2019 (COVID-19) infections world-wide and 1,637,053 deaths (University JH, 2020). The United States had the highest number of infections in the world, with 16,724,753 cases and 303,849 deaths. In Africa, South Africa had the highest number of cases (873,678) and deaths (23,661). The Republic of the Congo, with an estimated population of 5,300,000, had recorded 6200 cases and 100 deaths, as of December 12, 2020 (SITREP 115, Congo).
            High SARS-CoV-2 IgG/IGM seroprevalence in asymptomatic Congolese in Brazzaville, the Republic of Congo
          • Editorial
            Open Access

            COVID-19 travel restrictions and the International Health Regulations – Call for an open debate on easing of travel restrictions

            International Journal of Infectious Diseases
            Vol. 94p88–90Published online: April 16, 2020
            • Eskild Petersen
            • Brian McCloskey
            • David S. Hui
            • Richard Kock
            • Francine Ntoumi
            • Ziad A. Memish
            • Nathan Kapata
            • Esam I. Azhar
            • Marjorie Pollack
            • Larry C. Madoff
            • Davidson H. Hamer
            • Jean B. Nachega
            • N. Pshenichnaya
            • Alimuddin Zumla
            Cited in Scopus: 24
            • Preview Hide Preview
            • Download PDF
            • Export Citation
              The COVID-19 pandemic caused by the novel coronavirus (SARS-CoV-2) has made national governments worldwide to mandate several generic infection control measures such as physical distancing, self-isolation, and closure of non-essential shops, restaurants schools, among others. Some models suggest physical distancing would have to persist for 3 months to mitigate the peak effects on health systems and could be required on an intermittent basis for 12 to 18 months (Flaxman et al., 2020).
            • Editorial
              Open Access

              Li Wenliang, a face to the frontline healthcare worker. The first doctor to notify the emergence of the SARS-CoV-2, (COVID-19), outbreak

              International Journal of Infectious Diseases
              Vol. 93p205–207Published online: March 3, 2020
              • Eskild Petersen
              • David Hui
              • Davidson H. Hamer
              • Lucille Blumberg
              • Lawrence C. Madoff
              • Marjorie Pollack
              • Shui Shan Lee
              • Susan McLellan
              • Ziad Memish
              • Ira Praharaj
              • Sean Wasserman
              • Francine Ntoumi
              • Esam Ibraheem Azhar
              • Timothy D. Mchugh
              • Richard Kock
              • Guiseppe Ippolito
              • Ali Zumla
              • Marion Koopmans
              Cited in Scopus: 45
              • Preview Hide Preview
              • Download PDF
              • Export Citation
                Dr Li Wenliang, who lost his life to the novel coronavirus, SARS-CoV-2, became the face of the threat of SARS-CoV-2 to frontline workers, the clinicians taking care of patients. Li, 34, was an ophthalmologist at Wuhan Central Hospital. On 30th December, 2019, when the Wuhan municipal health service sent out an alert, he reportedly warned a closed group of ex-medical school classmates on the WeChat social media site of “Seven cases of severe acute respiratory syndrome (SARS) like illness with links with the Huanan Seafood Wholesale Market” at his hospital.
              • Editorial
                Open Access

                Is Africa prepared for tackling the COVID-19 (SARS-CoV-2) epidemic. Lessons from past outbreaks, ongoing pan-African public health efforts, and implications for the future

                International Journal of Infectious Diseases
                Vol. 93p233–236Published online: February 28, 2020
                • Nathan Kapata
                • Chikwe Ihekweazu
                • Francine Ntoumi
                • Tajudeen Raji
                • Pascalina Chanda-Kapata
                • Peter Mwaba
                • Victor Mukonka
                • Matthew Bates
                • John Tembo
                • Victor Corman
                • Sayoki Mfinanga
                • Danny Asogun
                • Linzy Elton
                • Liã Bárbara Arruda
                • Margaret J. Thomason
                • Leonard Mboera
                • Alexei Yavlinsky
                • Najmul Haider
                • David Simons
                • Lara Hollmann
                • Swaib A. Lule
                • Francisco Veas
                • Muzamil Mahdi Abdel Hamid
                • Osman Dar
                • Sarah Edwards
                • Francesco Vairo
                • Timothy D. McHugh
                • Christian Drosten
                • Richard Kock
                • Giuseppe Ippolito
                • Alimuddin Zumla
                Cited in Scopus: 112
                • Preview Hide Preview
                • Download PDF
                • Export Citation
                  Soon after the novel coronavirus, SARS-CoV-2 (2019-nCoV), was first identified in a cluster of patients with pneumonia (Li et al., 2020), in the Chinese city of Wuhan on 31 December 2019, rapid human to human transmission was anticipated (Hui et al., 2020). The fast pace of transmission is wreaking havoc and stirring media hype and public health concern (Ippolito et al., 2020) globally. When the World Health Organization (WHO) declared the disease, (now officially named COVID-19) a Public Health Emergency of International Concern (PHEIC) on 31st January 2020 (WHO, 2020a), the Director General Dr Tedros Ghebreyesus justified the decision by stating that WHOs greatest concern was the potential for the virus to spread to countries with weaker health systems.
                • Editorial
                  Open Access

                  The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China

                  International Journal of Infectious Diseases
                  Vol. 91p264–266Published online: January 14, 2020
                  • David S. Hui
                  • Esam I Azhar
                  • Tariq A. Madani
                  • Francine Ntoumi
                  • Richard Kock
                  • Osman Dar
                  • Giuseppe Ippolito
                  • Timothy D. Mchugh
                  • Ziad A. Memish
                  • Christian Drosten
                  • Alimuddin Zumla
                  • Eskild Petersen
                  Cited in Scopus: 2014
                  • Preview Hide Preview
                  • Download PDF
                  • Export Citation
                    The city of Wuhan in China is the focus of global attention due to an outbreak of a febrile respiratory illness due to a coronavirus 2019-nCoV. In December 2019, there was an outbreak of pneumonia of unknown cause in Wuhan, Hubei province in China, with an epidemiological link to the Huanan Seafood Wholesale Market where there was also sale of live animals. Notification of the WHO on 31 Dec 2019 by the Chinese Health Authorities has prompted health authorities in Hong Kong, Macau, and Taiwan to step up border surveillance, and generated concern and fears that it could mark the emergence of a novel and serious threat to public health (WHO, 2020a; Parr, 2020).
                  Page 1 of 1
                  Skip menu

                    Login to your account

                    Show
                    Forgot password?
                    Don’t have an account?
                    Create a Free Account

                    If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password

                    If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password

                    Cancel
                    • Home
                    • Articles & Issues
                    • Articles In Press
                    • Current Issue
                    • List of Issues
                    • Supplements
                    • Collections
                    • IJID COVID-19
                    • Emerging Infectious Diseases in the Time of Ebola
                    • Featured Content
                    • For Authors
                    • About Open Access
                    • Author Information
                    • Permissions
                    • Researcher Academy
                    • Submit a Manuscript
                    • Journal Info
                    • About the Journal
                    • About Open Access
                    • Contact Information
                    • Editorial Board
                    • Info for Advertisers
                    • Reprints
                    • New Content Alerts
                    • News and Media
                    • ISID
                    • ProMED
                    • More Periodicals
                    • Find a Periodical
                    • Go to Product Catalog
                    We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
                    Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.

                    • Privacy Policy  
                    • Terms and Conditions  
                    • Accessibility  
                    • Help & Contact

                    RELX